Status:
COMPLETED
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a study to understand efficacy and safety of investigational agent (PF-04937319) compared to approved agent (glimepiride) in patients with diabetes on metformin
Eligibility Criteria
Inclusion
- Age 18-70 yrs, male and females, with T2DM, on metformin alone or in combination with 1 other oral agent
Exclusion
- Subjects with recent cardiovascular events, those with evidence of diabetic complications
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT01517373
Start Date
February 1 2012
End Date
January 1 2013
Last Update
January 31 2017
Active Locations (53)
Enter a location and click search to find clinical trials sorted by distance.
1
Sierra Clinical Research
Roseville, California, United States, 95661
2
California Research Foundation
San Diego, California, United States, 92103
3
Diablo Clinical Research, Inc.
Walnut Creek, California, United States, 94598
4
Meridien Research
Bradenton, Florida, United States, 34208